New! Sign up for our free email newsletter.
Science News
from research organizations

Chimera viruses can help the fight against lymphomas

Date:
September 14, 2017
Source:
Instituto de Medicina Molecular
Summary:
Researchers have created a chimera virus that allows the study of molecules to treat cancers caused by human herpes virus infection in mice models of disease.
Share:
FULL STORY

Researchers from Instituto de Medicina Molecular (iMM) Lisboa have created a chimera virus that allows the study of molecules to treat cancers caused by human herpes virus infection in mice models of disease.

There are several types of herpesvirus able to infect humans, such as herpes simplex, chickenpox, cytomegalovirus, Epstein-Barr and Kaposi Sarcoma herpesvirus. One of the main characteristics of herpesviruses is their ability to infect their hosts for life and in a small percentage of these people ultimately lead to cancer.

Cancers associated with Kaposi virus infection have an Achilles heel: their cells' viability is directly dependent on the survival of the virus, which means that if the virus were to be eliminated cancer cells would no longer proliferate, hence the cancer would be cured.

In collaboration with a team from Harvard-Medical School, researchers led by Pedro Simas (iMM) and Kenneth Kaye (Harvard) studied a protein of the Kaposi virus vital for maintaining infection. Without this protein, called LANA, the virus looses its ability to cause cancer.

The team found that when LANA is cloned into a virus similar to Kaposi, but which infects mice instead of humans, it preserves its functionality. This finding came as a surprise since it was assumed that as a consequence of the evolutionary divergence between human and other animal viruses, the genes that code for LANA could not be switched.

However, the work now published in PlosPathogens, showed that even though there are more than 60 million years of evolutive divergence between the human Kaposi sarcoma herpesvirus and its rodent homologue, LANA's functional mechanisms are preserved.

These findings allowed researchers to create a chimera virus: a mouse virus with a human viral gene that can be used to test molecules that inhibit human LANA protein in an animal model of disease, treating not only human herpes virus infection but also its associated cancers. These molecules will hopefully be used in the future as drugs to treat Kaposi virus associated lymphomas.

"In addition to Kaposi virus the same experimental strategy to create chimera viruses, previously thought to be theoretically non-viable, can now be used for other viruses that use proteins similar to LANA, such as the Epstein-Barr virus which infects greater than 90% of the world population or the human papillomavirus responsible for cervical cancers," said Pedro Simas.


Story Source:

Materials provided by Instituto de Medicina Molecular. Note: Content may be edited for style and length.


Journal Reference:

  1. Aline C. Habison, Marta Pires de Miranda, Chantal Beauchemin, Min Tan, Sofia A. Cerqueira, Bruno Correia, Rajesh Ponnusamy, Edward J. Usherwood, Colin E. McVey, J. Pedro Simas, Kenneth M. Kaye. Cross-species conservation of episome maintenance provides a basis for in vivo investigation of Kaposi's sarcoma herpesvirus LANA. PLOS Pathogens, 2017; 13 (9): e1006555 DOI: 10.1371/journal.ppat.1006555

Cite This Page:

Instituto de Medicina Molecular. "Chimera viruses can help the fight against lymphomas." ScienceDaily. ScienceDaily, 14 September 2017. <www.sciencedaily.com/releases/2017/09/170914152251.htm>.
Instituto de Medicina Molecular. (2017, September 14). Chimera viruses can help the fight against lymphomas. ScienceDaily. Retrieved May 29, 2024 from www.sciencedaily.com/releases/2017/09/170914152251.htm
Instituto de Medicina Molecular. "Chimera viruses can help the fight against lymphomas." ScienceDaily. www.sciencedaily.com/releases/2017/09/170914152251.htm (accessed May 29, 2024).

Explore More

from ScienceDaily

RELATED STORIES